2024 ISPE Aseptic Conference

Conference Overview 

In the constantly evolving field of pharmaceutical manufacturing, the imperative to embrace new technologies and innovative strategies for process control and efficiency is more pressing than ever before.

Recent advancements in aseptic processing, such as advanced isolators, robotics, and increased automation, have transformed the industry whilst simultaneously reducing the risks of contamination for sterile products. However, modern therapies - innovative, targeted treatments that result in small-batch aseptic products - require faster speeds to market and present unique sterilization and handling challenges. This dichotomy presents unique challenges for the industry to address.

Moreover, the updated Annex 1 is impacting the manufacturing of sterile products, necessitating updated requirements such as Quality Risk Management, Contamination Control Strategy, and Data Management and Compliance for Computerized Systems.

In light of these urgent needs, the 2024 ISPE Aseptic Conference will provide an ideal opportunity for participants to share progress, success stories, best practices, and lessons learned. Get ahead of the game with a focus on novel therapies, emerging technologies, and aseptic processing. We look forward to seeing you in Vienna, Austria!

Featured Speakers

Conference Timeline

  • Notifications Sent - The notifications will be sent out during the week of 18 September

Conference Topics 

Given the impact of the evolving pandemic, an ageing population, the increase in diseases with unmet needs, and an unprecedented rise in chronic diseases, the need for a constant focus on collaborative innovation and agility will shape Pharma’s priorities in the foreseeable future. ISPE will be the leader in setting the pace for knowledge sharing that speaks to the current and future needs of the industry.   

The 2024 Aseptic Program Committee is requesting proposals aligning with the following content areas: 

Proposal Submission Type

Individual Oral Presentation

20-minute presentation, to be made part of a larger session by the Planning Committee. The presentation should focus on new and innovative trends, a specific real-world strategy or campaign, a case study/use case, or a “how-to" presentation intended to help attendees gain a better understanding of the initiative and best practices that can be applied to day-to-day objectives or overall mission.

Proposal Guidelines

  • All presentations must be free of commercial intent. Incomplete proposals will not be considered.
  • By submitting a proposal, you acknowledge that, if your proposal is accepted, the speaker will attend/present in-person at the event and the speaker’s attendance at the event will be supported by their organization. 
  • Accepted Aseptic Conference speakers are responsible for their own travel and accommodations.
  • Speakers (including co-speakers, panelists, keynotes and regulators) giving at least a 20-minute presentation (not including Q&A) receive complimentary conference registration. 
  • Poster Presenters receive a 20% discount on conference registration.
  • NOTE: Exhibitors who are accepted to present a poster are required to register as a paid conference attendee (with 20% discount off the prevailing registration rate).  Complimentary booth staffing registrations cannot be utilized for the poster presentations as these are part of the education sessions and not the exhibition. 
  • Consulting firms or vendors/suppliers are expected to include a speaker from an owner company to present. 
  • Regulators interested in submitting a proposal: Please contact Saana Tykka to submit your abstract.

Program Committee

Christa B. Myers
Sr. Fellow - Aseptic and Sterile Products, Vertical Market Leader
Jörg Zimmermann
Vice President Vetter Development Service External Affairs
Vetter Pharma Fertigung GmbH & Co KG
Past Chair
Massimiliano Cesarini, MSEng
Managing Director - Pharma
Omnia Technologies
Francesco Cicirello
Senior Director, Quality Assurance
Evelo Biosciences
Richard Denk
Senior Consultant Aseptic Processing & Containment
Matthew P. Gorton
Director of Business Development
GBA Life Sciences
Alexander Haig
Vice President, Operations
INCOG BioPharma Services, Inc.
Michael G. Higgins
Sr. Director External Engagement and Supplier Quality
Moderna Therapeutics
Ryan Paul Mazur
Process Engineer
Nidhi C. Shah
Senior Director, Value Stream CAR - T Manufacturing Operations
Bristol Myers Squibb
Klaus Ullherr
Senior Product Manager
Syntegon Technology GmbH
Keith W. Weseli, CPIP
Commissioning and Qualification Project Director
Stevanato Group